Cellular senescence in liver diseases: From mechanisms to therapies

被引:6
|
作者
Ge, Ting [1 ]
Shao, Yunyun [1 ]
Bao, Xiaofeng [1 ]
Xu, Wenxuan [2 ,4 ]
Lu, Chunfeng [1 ,3 ]
机构
[1] Nantong Univ, Sch Pharm, Nantong, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China
[3] Nantong Univ, Sch Pharm, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China
[4] China Pharmaceut Univ, Sch Life Sci & Technol, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Cellular senescence; Alcoholic liver disease; Nonalcoholic fatty liver disease; Liver fibrosis; Hepatocellular carcinoma; HEPATIC STELLATE CELL; OXIDATIVE STRESS; TELOMERE LENGTH; DAMAGE; EXPRESSION; INHIBITOR; BIOMARKER; ETHANOL; CANCER; DIET;
D O I
10.1016/j.intimp.2023.110522
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cellular senescence is an irreversible state of cell cycle arrest, characterized by a gradual decline in cell proliferation, differentiation, and biological functions. Cellular senescence is double-edged for that it can provoke organ repair and regeneration in physiological conditions but contribute to organ and tissue dysfunction and prime multiple chronic diseases in pathological conditions. The liver has a strong regenerative capacity, where cellular senescence and regeneration are closely involved. Herein, this review firstly introduces the morphological manifestations of senescent cells, the major regulators (p53, p21, and p16), and the core pathophysiologic mechanisms underlying senescence process, and then specifically generalizes the role and interventions of cellular senescence in multiple liver diseases, including alcoholic liver disease, nonalcoholic fatty liver disease, liver fibrosis, and hepatocellular carcinoma. In conclusion, this review focuses on interpreting the importance of cellular senescence in liver diseases and summarizes potential senescence-related regulatory targets, aiming to provide new insights for further researches on cellular senescence regulation and therapeutic developments for liver diseases.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Cellular senescence in ageing: from mechanisms to therapeutic opportunities
    Raffaella Di Micco
    Valery Krizhanovsky
    Darren Baker
    Fabrizio d’Adda di Fagagna
    Nature Reviews Molecular Cell Biology, 2021, 22 : 75 - 95
  • [22] Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies
    Lucas, Vasco
    Cavadas, Claudia
    Aveleira, Celia Alexandra
    PHARMACOLOGICAL REVIEWS, 2023, 75 (04) : 675 - 713
  • [23] Cellular senescence in ageing: from mechanisms to therapeutic opportunities
    Di Micco, Raffaella
    Krizhanovsky, Valery
    Baker, Darren
    di Fagagna, Fabrizio d'Adda
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2021, 22 (02) : 75 - 95
  • [24] Molecular mechanisms of cellular senescence
    di Fagagna, F. d'Adda
    EJC SUPPLEMENTS, 2010, 8 (05): : 6 - 7
  • [25] Mechanisms and functions of cellular senescence
    Herranz, Nicolas
    Gil, Jesus
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (04): : 1238 - 1246
  • [26] Molecular mechanisms of cellular senescence
    di Fagagna, F. d'Adda
    FEBS JOURNAL, 2011, 278 : 45 - 45
  • [27] Molecular mechanisms of cellular senescence
    di Fagagna, F. d'Adda
    EJC SUPPLEMENTS, 2008, 6 (09): : 35 - 35
  • [28] Mechanisms and Regulation of Cellular Senescence
    Roger, Laureline
    Tomas, Fanny
    Gire, Veronique
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [29] Cellular therapies in arthritic diseases
    Barry, F.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2009, 90 (02) : A105 - A105
  • [30] Cellular Senescence in Cardiovascular Diseases: From Pathogenesis to Therapeutic Challenges
    Li, Dan
    Li, Yongnan
    Ding, Hong
    Wang, Yuqin
    Xie, Yafei
    Zhang, Xiaowei
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (10)